Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)

Clinical trial NCT04572841 · COMPLETED

Trial details

NCT number: NCT04572841
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sjögren's Syndrome Sjogren's Syndrome

Start date: 2020-11-12
Primary completion: 2023-11-08
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.